Anzeige
Mehr »
Login
Dienstag, 30.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Basin Uranium: Es geht los! Der Uran-Superzyklus ist gestartet!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
66 Leser
Artikel bewerten:
(0)

AdvaMed 2012 Kicks Off Tomorrow in Boston

Medical Technology Industry's Largest North American Conference Features Business Partnering, Policy Updates

BOSTON, Sept. 30, 2012 /PRNewswire-USNewswire/ --AdvaMed 2012: The MedTech Conference, one of the largest medical technology events in the world, opens Monday, Oct. 1 in Boston, and has more than doubled in attendance in the past five years. Building on the success of the initial years of the conference, professionals with regulatory, reimbursement, business development, legal, IP, marketing, quality, compliance and other responsibilities, will convene at the Boston Convention and Exhibition Center to learn and share insights on public policies, advancements and new technologies in the market.

"Across the globe, medical technology is helping people lead healthier lives and helping build healthier economies by fighting chronic disease, keeping individuals in the workforce and helping to drive value in quality care. AdvaMed 2012 attendees will be able to learn the latest about the policies and the business developments that will shape our industry in the years to come," said Stephen J. Ubl, president and CEO of the Advanced Medical Technology Association (AdvaMed). "Boston is a world-class medical technology center and an ideal location for people to learn more about what is going on in our dynamic and fast-changing industry as we face an unprecedented period of change in the regulatory and payment policy arenas."

Medical technology is one of the fastest growing manufacturing industries, creating nearly two million jobs in the U.S. Massachusetts is home to 82,000 medical technology jobs at an average salary of nearly $67,000, and the industry contributes $17.6 billion to the state economy.

The conference will open Monday with its Medical Technology Veterans Program (MVP) Boot Camp for Returning Heroes.Through this initiative, returning veterans will receive career building skills and advice as well as job-search assistance and networking opportunities. In addition, CEO Unplugged sessions on Monday will focus on a range of subjects including payment and healthcare delivery as well as how collaborating with manufacturers can create value for healthcare providers.

This three-day conference will feature more than 40 educational panels led by medical technology visionaries. For example, an educational workshop on Monday will address the impact of business and regulatory developments in bringing medical devices to the U.S. market. CEO Unplugged sessions on Tuesday will explore the technology and regulatory environment as well as emerging growth company issues and policy and advocacy in the sector. On Wednesday, some of the industry's leading figures will address the upcoming medical device excise tax.

A special feature will be Innovation Alley, where 10 companies will display their life-changing innovations and cutting-edge technology. In the Massachusetts Pavilion in the exhibit hall, a cluster of companies from the state will feature their innovative products and services.

For a full conference agenda, visit www.advamed2012.com.

About AdvaMed 2012
Focused on bringing venture capital, angel and private equity investors together with industry stakeholders and addressing policy issues, AdvaMed 2012 brings together industry leaders from across the U.S. and around the world. Visit www.advamed2012.com for more details.

SOURCE AdvaMed 2012

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2012 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.